Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,060 | 2,560 | 4,350 | 5,110 | 1,710 |
| Other current assets | 200 | 180 | 170 | 140 | 130 |
| TOTAL | $1,260 | $2,740 | $4,520 | $5,250 | $1,840 |
| Non-Current Assets | |||||
| PPE Net | 820 | 730 | 600 | 600 | 550 |
| Other Non-Current Assets | 26,290 | 26,510 | 26,540 | 26,840 | 26,390 |
| TOTAL | $27,110 | $27,240 | $27,140 | $27,440 | $26,940 |
| Total Assets | $28,110 | $29,740 | $31,400 | $32,460 | $28,580 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 770 | 680 | 520 | 630 | 630 |
| Accrued Expenses | 90 | 240 | 250 | 290 | 460 |
| Other current liabilities | 0 | 0 | 0 | 20 | 0 |
| TOTAL | $2,360 | $2,420 | $2,270 | $2,450 | $5,390 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,360 | $2,420 | $2,270 | $2,450 | $5,390 |
| Shareholders' Equity | |||||
| Common Shares | 1,040 | 1,030 | 1,030 | 1,000 | 520 |
| Retained earnings | -26,380 | -24,160 | -20,960 | -16,240 | -8,490 |
| Other shareholders' equity | 10 | 0 | -10 | 0 | 0 |
| TOTAL | $25,750 | $27,310 | $29,130 | $30,000 | $23,180 |
| Total Liabilities And Equity | $28,110 | $29,730 | $31,400 | $32,450 | $28,570 |